Tata Motors, Nykaa, Ola Electric, Hi-Tech Pipes, and More - Heres a quick recap of stocks that are likely to attract ...

The RSV vaccines have gone through extensive testing. Last year, more than 20 million older adults were vaccinated safely.

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

The state reported that close to 156,000 residents have gotten the latest COVID-19 booster, at a time when cases are the highest they've been since Jan. 2022.

The CDC is attempting to get the COVID-19 shot into more arms by asking physicians and pharmacists to recommend the updated ...

In September, Quebec launched an RSV vaccination campaign for Quebecers who are at least 60 years old and living in long-term ...

One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...

Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist ...

Newfoundland and Labrador is rolling out its fall vaccination plan, effective Oct. 21. Appointments can now be made over the ...

STORY: Shares of Pfizer rose as much as four percent in Monday morning trading after activist investor Starboard Value took ...

Flu and RSV cases remain low in Connecticut, with the great majority of respiratory illness cases reported to DPH "all ...

Pfizer (PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (GSK) patents for its RSV vaccine.